Cite
MLA Citation
Robert L Coleman et al.. “2022-RA-249-ESGO Overall survival results from ariel3: a phase 3 randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma.” International journal of gynecological cancer, vol. 32, n.d., p. A226. http://access.bl.uk/ark:/81055/vdc_100168339855.0x000048